Patents by Inventor Egbert Siegfried MUNDT

Egbert Siegfried MUNDT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC COMPOSITIONS AND VACCINES COMPRISING AFRICAN SWINE FEVER VIRUS PEPTIDES AND PROTEINS AND USES THEREOF
    Publication number: 20230277648
    Abstract: The present invention relates to African swine fever virus (ASFV) peptides and/or polypeptides as well as immunogenic fragments thereof, corresponding encoding AFSV oligonucleotides and/or polynucleotides as well as immunogenic fragments thereof, immunogenic compositions, vaccines and uses thereof.
    Type: Application
    Filed: December 16, 2022
    Publication date: September 7, 2023
    Inventors: Veljko NIKOLIN, Egbert Siegfried MUNDT, Fernando Rodriguez GONZALEZ, Laia Bosch CAMOS, Javier Alonso COLLADO MIGUENS
  • H52 IBV vaccine with heterologous spike protein
    Patent number: 11696947
    Abstract: The present invention relates i.a. to an H52 IBV (infectious bronchitis virus) encoding for a heterologous S (spike) protein or fragment thereof. Further, the present invention relates to an immunogenic composition comprising said H52 IBV encoding for a heterologous S (spike) protein or fragment thereof. Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by IBV in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: July 11, 2023
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Annika Kraemer-Kuehl, Egbert Siegfried Mundt, Hans-Christian Philipp
  • Immunogenic compositions and vaccines comprising African swine fever virus peptides and proteins and uses thereof
    Patent number: 11628214
    Abstract: The present invention relates to African swine fever virus (ASFV) peptides and/or polypeptides as well as immunogenic fragments thereof, corresponding encoding AFSV oligonucleotides and/or polynucleotides as well as immunogenic fragments thereof, immunogenic compositions, vaccines and uses thereof.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: April 18, 2023
    Inventors: Veljko Nikolin, Egbert Siegfried Mundt, Fernando Rodriguez Gonzalez, Laia Bosch Camos, Javier Alonso Collado Miguens
  • ATTENUATED IBV WITH EXTENDED CELL CULTURE AND TISSUE TROPISM
    Publication number: 20220202931
    Abstract: The present invention relates i.a. to an IBV (infectious bronchitis virus) deposited with the BVR of IZSLER under accession number DPS RE RSCIC 16, any descendant IBV thereof and any IBV having all of the identifying characteristics of the deposited IBV. Further, the present invention relates to an immunogenic composition comprising said deposited IBV.
    Type: Application
    Filed: May 6, 2020
    Publication date: June 30, 2022
    Inventors: Egbert Siegfried MUNDT, Annika KRAEMER-KUEHL, Rosalba DE LA MORA QUIROZ, Jose Francisco ROBLES GONZALEZ, Thomas Min Stephan
  • IMMUNOGENIC COMPOSITION AGAINST AVIAN INFLUENZA VIRUS H5 SUBTYPE
    Publication number: 20220009970
    Abstract: The invention relates to the field of veterinary medicine. The invention provides an immunogenic composition, comprising a hemagglutinin protein of avian influenza virus H5 subtype. Also provided is a method of differentiating animals naturally infected with AIV from animals vaccinated with the immunogenic composition of the invention. The immunogenic composition of the invention can provide a broader, more effective, long-lasting and early onset protection on poultry.
    Type: Application
    Filed: November 5, 2019
    Publication date: January 13, 2022
    Inventors: Egbert Siegfried MUNDT, Xiaoping CUI, Zenglei HU
  • IMMUNOGENIC COMPOSITIONS AND VACCINES COMPRISING AFRICAN SWINE FEVER VIRUS PEPTIDES AND PROTEINS AND USES THEREOF
    Publication number: 20200306360
    Abstract: The present invention relates to African swine fever virus (ASFV) peptides and/or polypeptides as well as immunogenic fragments thereof, corresponding encoding AFSV oligonucleotides and/or polynucleotides as well as immunogenic fragments thereof, immunogenic compositions, vaccines and uses thereof.
    Type: Application
    Filed: March 26, 2020
    Publication date: October 1, 2020
    Inventors: Veljko NIKOLIN, Egbert Siegfried MUNDT, Fernando Rodriguez GONZALEZ, Laia Bosch CAMOS, Javier Alonso COLLADO MIGUENS
  • H52 IBV VACCINE WITH HETEROLOGOUS SPIKE PROTEIN
    Publication number: 20200129614
    Abstract: The present invention relates i.a. to an H52 IBV (infectious bronchitis virus) encoding for a heterologous S (spike) protein or fragment thereof. Further, the present invention relates to an immunogenic composition comprising said H52 IBV encoding for a heterologous S (spike) protein or fragment thereof. Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by IBV in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.
    Type: Application
    Filed: October 28, 2019
    Publication date: April 30, 2020
    Inventors: Annika KRAEMER-KUEHL, Egbert Siegfried MUNDT, Hans-Christian PHILIPP
  • H5 PROTEINS OF H5N1 INFLUENZA VIRUS FOR USE AS A MEDICAMENT
    Publication number: 20160361409
    Abstract: The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA. In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, wherein the H5N1 virus of a different clade comprises a particular polynucleotide and/or H5 protein.
    Type: Application
    Filed: August 25, 2016
    Publication date: December 15, 2016
    Inventor: Egbert Siegfried MUNDT
  • H5 PROTEINS OF H5N1 INFLUENZA VIRUS FOR USE AS A MEDICAMENT
    Publication number: 20140234357
    Abstract: The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA. In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, wherein the H5N1 virus of a different clade comprises a particular polynucleotide and/or H5 protein.
    Type: Application
    Filed: February 20, 2014
    Publication date: August 21, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventor: Egbert Siegfried MUNDT